BioArctic AB (publ) (STO:BIOA.B)

BioArctic AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,081	1,040	512.93	611.57	805.39	848.41
Short-Term Investments	908.65	1,150	265.99	500	-	-
Cash & Short-Term Investments	1,990	2,190	778.92	1,112	805.39	848.41
Cash Growth	3.85%	181.22%	-29.93%	38.02%	-5.07%	-15.15%
Accounts Receivable	-	121.65	71.2	0.22	-	2.84
Other Receivables	-	165.26	142.36	31.55	7.96	6.21
Receivables	-	286.91	213.55	31.77	7.96	9.04
Prepaid Expenses	-	9.62	18.2	9.4	7.5	4.34
Other Current Assets	687.02	-	-	-0	0	-
Total Current Assets	2,677	2,487	1,011	1,153	820.84	861.79
Property, Plant & Equipment	136.96	82.98	96.62	31.13	35.26	33.75
Long-Term Deferred Tax Assets	1.52	1.46	0.96	0.57	0.6	0.61
Other Long-Term Assets	3.55	3.83	3.44	1.65	1.61	1.59
Total Assets	2,819	2,575	1,112	1,186	858.31	897.73

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	-	23.94	50.45	29.87	21.49	11.82
Accrued Expenses	539.31	334.06	68.34	48.85	35.11	18.32
Current Portion of Leases	17.48	15.72	13.15	2.83	8.86	8.09
Current Income Taxes Payable	-	136.71	33.58	33.76	-	-
Current Unearned Revenue	-	-	-	-	-	59.12
Other Current Liabilities	113.84	10.34	10.14	9.67	5.43	3.92
Total Current Liabilities	670.63	520.78	175.66	124.97	70.88	101.27
Long-Term Leases	73.12	28.35	41.08	2.15	1.18	7.79
Long-Term Deferred Tax Liabilities	59.02	59.02	-	12.39	-	-
Other Long-Term Liabilities	-	-	-	-	0	0
Total Liabilities	802.78	608.15	216.74	139.5	72.07	109.05

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2,016	1.77	1.77	1.77	1.76	1.76
Additional Paid-In Capital	-	613.11	587.1	580.98	566	560.02
Retained Earnings	-	1,351	305.07	462.87	217.52	225.94
Comprehensive Income & Other	-	0.77	1	0.96	0.96	0.96
Total Common Equity	2,016	1,967	894.94	1,047	786.24	788.68
Shareholders' Equity	2,016	1,967	894.94	1,047	786.24	788.68
Total Liabilities & Equity	2,819	2,575	1,112	1,186	858.31	897.73

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	90.61	44.07	54.23	4.98	10.04	15.88
Net Cash (Debt)	1,899	2,146	724.69	1,107	795.35	832.53
Net Cash Growth	1.73%	196.18%	-34.51%	39.13%	-4.47%	-14.98%
Net Cash Per Share	21.36	24.19	8.19	12.51	8.97	9.45
Filing Date Shares Outstanding	85.92	88.64	88.39	88.31	88.13	88.06
Total Common Shares Outstanding	85.92	88.64	88.39	88.31	88.13	88.06
Working Capital	2,006	1,966	835	1,028	749.96	760.52
Book Value Per Share	23.47	22.19	10.13	11.85	8.92	8.96
Tangible Book Value	2,016	1,967	894.94	1,047	786.24	788.68
Tangible Book Value Per Share	23.47	22.19	10.13	11.85	8.92	8.96
Machinery	-	82.71	72.47	57.11	50.33	39.77
Leasehold Improvements	-	17.79	17.79	6.52	6.52	4.33

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 27, 2026

Data Sources Report a data error